{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T20:54:40Z","timestamp":1761598480965,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016879","name":"UCB SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016879","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.yebeh.2022.109018","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:51:03Z","timestamp":1671130263000},"page":"109018","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Brivaracetam or levetiracetam in status epilepticus?: Lessons from the photosensitivity model"],"prefix":"10.1016","volume":"138","author":[{"given":"Dorothee","family":"Kasteleijn-Nolst Trenite","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yebeh.2022.109018_b0005","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/archneurpsyc.1936.02260120083006","article-title":"Effect on the Electro-encephalogram of drugs and conditions which influence seizures","volume":"36","author":"Lennox","year":"1936","journal-title":"Arch Neurol Psychiat"},{"issue":"70\u201371","key":"10.1016\/j.yebeh.2022.109018_b0010","article-title":"Photic driving as a cause of clinical seizures in epileptic patients","volume":"58","author":"Cobb","year":"1947","journal-title":"Arch Neurol Psychiat"},{"issue":"170","key":"10.1016\/j.yebeh.2022.109018_b0015","article-title":"Convulsive effects of light stimulation in children","volume":"86","author":"Bickford","year":"1953","journal-title":"Amer J Dis Child"},{"key":"10.1016\/j.yebeh.2022.109018_b0020","first-page":"12","article-title":"Tridione","volume":"3","author":"Anonymous","year":"1946","journal-title":"Bull Am Soc Hospital Pharm"},{"key":"10.1016\/j.yebeh.2022.109018_b0025","unstructured":"Kasteleijn-Nolst Trenit\u00e9 DG. Photosensitivity in epilepsy. Electrophysiological and clinical correlates. Acta Neurol Scand Suppl 1989;125:3\u2013149. PMID 2618589."},{"key":"10.1016\/j.yebeh.2022.109018_b0030","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0013-4694(86)90060-X","article-title":"Photosensitivity as a model for acute antiepileptic drug studies","volume":"63","author":"Binnie","year":"1986","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"6","key":"10.1016\/j.yebeh.2022.109018_b0035","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.seizure.2014.03.011","article-title":"How predictive are photosensitive epilepsy models as proof of principle trials for epilepsy?","volume":"23","author":"Yuen","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2022.109018_b0040","doi-asserted-by":"crossref","unstructured":"Reed RC, Rosenfeld WE, Lippmann SM, Abou-Khalil B, Kasteleijn-Nolst Trenit\u00e9 DG. Creative use of the conventional \u2018human photosensitivity model in epilepsy (Chapter 24). In: The importance of photosensitivity for epilepsy, Springer-Nature, Switzerland AG; 2021. https:\/\/doi.org\/10.1007\/978-3-319-05080-5.","DOI":"10.1007\/978-3-319-05080-5_24"},{"issue":"3","key":"10.1016\/j.yebeh.2022.109018_b0045","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archneur.1973.00490270073012","article-title":"Serum Concentrations of Diazepam in Subjects With Epilepsy","volume":"29","author":"Booker","year":"1973","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2022.109018_b0050","doi-asserted-by":"crossref","unstructured":"Kasteleijn-Nolst Trenit\u00e9 D, Rubboli G, Hirsch E, Martins da Silva A, Seri S, Wilkins A, et al. Methodology of photic stimulation revisited: updated European algorithm for visual stimulation in the EEG laboratory. Epilepsia 2012;53:16\u201324. https:\/\/doi:10.1111\/j.1528-1167.2011.03319.x.","DOI":"10.1111\/j.1528-1167.2011.03319.x"},{"issue":"8","key":"10.1016\/j.yebeh.2022.109018_b0055","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/epi.16279","article-title":"Inhaled alprazolam rapidly suppresses epileptic activity in photosensitive participants","volume":"60","author":"French","year":"2019","journal-title":"Epilepsia"},{"issue":"22","key":"10.1016\/j.yebeh.2022.109018_b0060","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.yebeh.2022.109018_b0065","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/01.STR.0000196957.55928.ab","article-title":"Time Is Brain\u2014Quantified","volume":"37","author":"Saver","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2022.109018_b0070","doi-asserted-by":"crossref","unstructured":"Matagne A, Margineanu D-G, Kenda B, Michel P, Klitgaard H. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A. Brit J Pharmacol 2008;154:1662\u201371. https:\/\/doi: 10.1038\/bjp.2008.198.","DOI":"10.1038\/bjp.2008.198"},{"key":"10.1016\/j.yebeh.2022.109018_b0075","doi-asserted-by":"crossref","unstructured":"Klitgaard H, Matagne A, Nicolas J-M, Gillard M, Lamberty Y, De Ryck M, et al. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment. Epilepsia 2016;57(4):538\u201348. https:\/\/doi:10.1111\/epi.13340.","DOI":"10.1111\/epi.13340"},{"issue":"3","key":"10.1016\/j.yebeh.2022.109018_b0080","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1021\/jm030913e","article-title":"Discovery of 4-Substituted Pyrrolidone Butanamides as New Agents with Significant Antiepileptic Activity","volume":"47","author":"Kenda","year":"2004","journal-title":"J Med Chem"},{"issue":"1-3","key":"10.1016\/j.yebeh.2022.109018_b0085","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2011.04.064","article-title":"Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties","volume":"664","author":"Gillard","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.yebeh.2022.109018_b0090","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1111\/epi.14701","article-title":"A single\u2010center, open\u2010label positron emission tomography study to evaluate brivaracetam and levetiracetam synaptic vesicle glycoprotein 2A binding in healthy volunteers","volume":"60","author":"Finnema","year":"2019","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2022.109018_b0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0920-1211(96)00031-9","article-title":"Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue levetiracetam","volume":"25","author":"Kasteleijn-Nolst Trenit\u00e9","year":"1996","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.yebeh.2022.109018_b0100","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1212\/01.wnl.0000271385.85302.55","article-title":"Evaluation of brivaracetam, a novel SV2A ligand, in the photosensitivity model","volume":"69","author":"Kasteleijn-Nolst Trenite","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2022.109018_b0105","doi-asserted-by":"crossref","unstructured":"Reed RC, Rosenfeld WE, Lippmann SM, Eijkemans RMJC, Kasteleijn-Nolst Trenit\u00e9 DGA. Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in PhotosensitiveEpilepsy Patients. CNS Drugs 2020;34(10):1075\u201386. https:\/\/doi:10.1007\/s40263-020-00761-1.","DOI":"10.1007\/s40263-020-00761-1"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502200467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550502200467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:50:46Z","timestamp":1761504646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550502200467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":21,"alternative-id":["S152550502200467X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.109018","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brivaracetam or levetiracetam in status epilepticus?: Lessons from the photosensitivity model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2022.109018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109018"}}